Review of analytical methods for identification and determination of triptans

Critical Reviews in Analytical Chemistry

Volumn 39, Issue 1, 2009, Pages 32-42

  Saka, Cafer ^a  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

Identification and determination methods; Migraine; Review; Serotonin; Triptans

Indexed keywords

IDENTIFICATION AND DETERMINATION METHODS; MIGRAINE; REVIEW; SEROTONIN; TRIPTANS;

ANALYTICAL METHOD; CHROMATOGRAPHY; DISEASE; ELECTROCHEMISTRY; ELECTROKINESIS; IDENTIFICATION METHOD; SPECTROMETRY;

EID: 59249090689     PISSN: 10408347     EISSN: 15476510     Source Type: Journal    
DOI: 10.1080/10408340802569522     Document Type: Review

References (70)

1. Stewart, W. F., Lipton, R. B., Chee, E., Sawyer, J. and Silberstein, S. D. (2000) Menstrual cycle and headache in a population sample of migraineurs. Neurology, 55, pp. 1517-1523.
2. Hargraves, R. J. and Shepherd, S. L. (1999) Pathophysiology of migraine - new insights. Canadian Journal of Neurological Sciences, 26, pp. 12-19.
3. Tfelt-Hansen, P., Saxena, P. R., Dahlöf, C., Pascual, J., Láinez, M., Henry, P., Diener, H.-C., Schoenen, J., Ferrari, M. D. and Goadsby, P. J. (2000) Ergotamine in the acute treatment of migraine: A review and European consensus. Brain, 123, pp. 9-18.
4. Goadsby, P. J., Lipton, R. B. and Ferrari, M. D. (2002) Migraine-current understanding and treatment. The New England Journal of Medicine, 346, pp. 257-270.
5. Snyder, L. R. and Kirkland, J. J. (1979) Introduction to Modern Liquid Chromatography,, Wiley, Canada
6. Skoog, D. A. and Leary, J. J. (1992) Principles of Instrumental Analysis,, Saunders College Publishing, New York
7. Tanaka, N., Goodell, H. and Karger, B. L. (1978) The role of organic modifiers on polar group selectivity in reversed-phase liquid chromatography. Journal of Chromatography, 158, pp. 233-248.
8. Schomburg, G. (1988) Stationary phases in high performance liquid chromatography. LC-GC, 6, pp. 36-50.
9. Bowers, G. D., Clegg, C. P., Hughes, S. C., Harker, A. J. and Lambert, S. (1997) Automated SPE and tandem MS without HPLC columns for quantifying drugs at the picogram level. LC GC, 15, pp. 48-53.
10. Kerns, E. H., Rourick, R. A., Volk, K. J. and Lee, M. S. (1997) Buspirone metabolite structure profile using a standard liquid chromatographic-mass spectrometric protocol. Journal of Chromatography B, Biomedical Sciences and Applications, 698, pp. 133-145.
11. Dear, G. J., Harrelson, J. C., Jones, A. E., Johnson, T. E. and Pleasance, S. (1995) Identification of the urinary and biliary conjugated metabolites of the neuromuscular blocker 51W89 by liquid chromatography/mass spectrometry. Rapid Communications in Mass Spectrometry, 9, pp. 1457-1464.
12. Esther, F. and Tibor, C. (1997) Relationship between the hydrophobicity and specific hydrophobic surface area of pesticides determined by high-performance liquid chromatography compared with reversed-phase thin-layer chromatography. Journal of Chromatography A, 771, pp. 105-109.
13. Ayrton, J., Dear, G. J., Leavens, W. J., Mallett, D. N. and Plumb, R. S. (1998) Optimisation and routine use of generic ultra-high flow-rate liquid chromatography with mass spectrometric detection for the direct on-line analysis of pharmaceuticals in plasma. Journal of Chromatography A, 828, pp. 199-207.
14. Oxford, J. and Lant, M. S. (1989) Development and validation of a liquid chromatographic-mass spectrometric assay for the determination of sumatriptan in plasma. Journal of Chromatography, 88, pp. 137-146.
15. Andrew, P. D., Birch, H. L. and Phillpot, D. A. (1993) Determination of sumatriptan succinate in plasma and urine by high performance liquid chromatography with electrochemical detection. Journal of Pharmaceutical Sciences, 82, pp. 73-76.
16. McLoughlin, D. A., Olah, T. V., Ellis, J. D., Gilbert, J. D. and Halpin, R. A. (1996) Quantitation of the 5HT1D agonists MK-462 and sumatriptan in plasma by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry. Journal of Chromatography A, 726, pp. 115-124.
17. Dunne, M. and Andrew, P. (1996) Fully automated assay for the determination of sumatriptan in human serum using solid-phase extraction and high-performance liquid chromatography with electrochemical detection. Journal of Pharmaceutical and Biomedical Analysis, 14, pp. 721-726.
18. Ge, Z., Tessier, E., Neirinck, E. and Zhu, Z. (2004) High performance liquid chromatographic method for the determination of sumatriptan with fluorescence detection in human plasma. Journal of Chromatography, 809, pp. 299-303.
19. Nozal, M. J., Bernal, J. L., Toribio, L., Martin, M. T. and Diez, F. J. (2002) Development and validation of an LC assay for sumatriptan succinate residues on surfaces in the manufacture of pharmaceuticals. Journal of Pharmaceutical and Biomedical Analysis, 30, pp. 285-291.
20. Shirsat, V. A., Gabhe, S. Y. and Deshpande, S. G. (1998) High performance liquid chromatographic determination of sumatriptan succinate from pharmaceutical preparation. Indian Drugs, 358, pp. 404-407.
21. Xu, X., Bartlett, M. G. and Stewart, J. T. (2001) Determination of degradation products of sumatriptan succinate using LC-MS and LC-MS-MS. Journal of Pharmaceutical and Biomedical Analysis, 26, pp. 367-377.
22. Boulton, D. W., Duncan, G. F. and Vachharajani, N. N. (2003) Validation and application of a high-performance liquid chromatography/tandem mass spectrometry assay for sumatriptan in human plasma. Biomedical Chromatography, 17, pp. 48-52.
23. Majithiya, R. J., Majithiya, J. B., Umrethia, M. L., Ghosh, P. K. and Murthy, R. S. R. (2006) HPLC method for the determination of sumatriptan in plasma and brain tissue. Ars Pharmaceutica, 47, pp. 199-210.
24. Tan, A., Hanga, P., Couture, J., Hussain, S. and Vallee, F. (2007) An evaporation-free solid-phase extraction method for rapid and accurate analysis of sumatriptan in human plasma by LC-MS/MS. Journal of Chromatography B, 856, pp. 9-14.
25. Cheng, K. N., Redrup, M. J., Barrow, A. and Williams, P. N. (1998) Validation of a liquid chromatographic tandem mass spectrometric method for the determination of sumatriptan in human biolgical fluids. Journal of Pharmaceutical and Biomedical Analysis, 17, pp. 399-408.
26. Franklin, M., Odontiadis, J. and Clement, E. M. (1996) Determination of sumatriptan succinate in human plasma by high-performance liquid chromatography with coulometric detection and utilization of solid-phase extraction. Journal of Chromatography B, Biomedical Applications, 681, pp. 416-420.
27. Vishwanathan, K., Bartlett, M. G. and Stewart, J. T. (2000) Determination of antimigraine compounds rizatriptan, zolmitriptan, naratriptan and sumatriptan in human serum by liquid chromatography/ electrospray tandem mass spectrometry. Rapid Communications in Mass Spectrometry, 14, pp. 168-172.
28. Tipre, D. N. and Vavia, P. R. (1999) Estimation of sumatriptan succinate in pharmaceutical dosage form by spectrophotometric and hptlc method. Indian Drugs, 36, pp. 501-505.
29. Singh, S. and Jain, R. (1997) Stability indicating HPLC method for the determination of sumatriptan succinate in pharmaceutical preparations and its application in dissolution rate studies. Indian Drugs, 34, pp. 527-531.
30. Femenía-Font, A., Merino, V., Rodilla, V. and López-Castellano, A. (2005) High-performance liquid chromatographic determination of sumatriptan after in vitro transdermal diffusion studies. Journal of Pharmaceutical and Biomedical Analysis, 37, pp. 621-626.
31. Ding, J.-S., Zhu, R.-H., Zhu, Y.-G. and Li, H.-D. (2006) Determination of zolmitriptan in human plasma by HPLC-MS and study on bioequilvalence of domestic and important zolmitriptan tablets. Chinese Pharmaceutical Journal, 41, pp. 1488-1490.
32. Kiliç, B., Özden, T., Toptan, S. and Özilhan, S. (2007) Simultaneous LC-MS-MS determination of zolmitriptan and its active metabolite N-desmethylzolmitriptan in human plasma. Chromatographia, 66, pp. 129-133.
33. Srinivasu, M. K., Mallikarjuna Rao, B., Sridhar, G., Kumar, P. R., Chandrasekhar, K. B. and Islam, A. (2005) A validated chiral LC method for the determination of zolmitriptan and its potential impurities. Journal of Pharmaceutical and Biomedical Analysis, 37, pp. 453-460.
34. Srinivasu, M. K., Mallikarjuna Rao, B., Sridhar, G., Kumar, P. R. and Chandrasekhar, K. B. (2005) A validated chiral LC method for the enantiomeric separation of Zolmitriptan key intermediate, ZTR-5. Journal of Pharmaceutical and Biomedical Analysis, 39, pp. 796-800.
35. Mallikarjuna Rao, B., Srinivasu, M. K., Sridhar, G., Kumar, P. R., Chandrasekhar, K. B. and Islam, A. (2005) A stability indicating LC method for zolmitriptan. Journal of Pharmaceutical and Biomedical Analysis, 39, pp. 503-509.
36. Chen, X., Liu, D., Luan, Y., Jin, F. and Zhong, D. (2006) Determination of zolmitriptan in human plasma by liquid chromatography-tandem mass spectrometry method: Application to a pharmacokinetic study. Journal of Chromatography B, 832, pp. 30-35.
37. Chen, J., Jiang, W., Jiang, X.-G., Mei, N., Gao, X.-L. and Zhang, Q.-Z. (2004) High-performance liquid chromatographic analysis of zolmitriptan in human plasma using fluorescence detection. Journal of Pharmaceutical and Biomedical Analysis, 35, pp. 639-645.
38. Zhang, Z., Xu, F., Tian, Y., Li, W. and Mao, G. (2004) Quantification of zolmitriptan in plasma by high-performance liquid chromatography-electrospray ionization mass spectrometry. Journal of Chromatography B, 813, pp. 227-233.
39. Clement, E. M. and Franklin, M. (2002) Simultaneous measurement of zolmitriptan and its major metabolites N-desmethylzolmitriptan and zolmitriptan N-oxide in human plasma by high performance liquid chromatography with coulometric determination. Journal of Chromatography B, 766, pp. 339-343.
40. Hu, Y. Z., Yao, T. W. and Wang, X. J. (2004) HPLC determination of zolmitriptan and its related substances. Journal of Zhejiang University Science, 33, pp. 37-40.
41. Yu, L., Yao, T., Ni, S. and Zeng, S. (2005) Determination of zolmitriptan enantiomers in rat liver microsomes by chiral high performance liquid chromatography with fluorescence detection. Biomedical Chromatography, 19, pp. 191-195.
42. Guo, J., Zhang, A.-J., Zhao, L., Sun, X.-H., Zhao, Y.-M., Gao, H.-Z., Liu, Z.-Y. and Qiao, S.-Y. (2005) Determination of rizatriptan in human plasma by liquid chromatographic-eletrospray tandem mass spectrometry: Application to a pharmacokinetic study. Biomedical Chromatography, 20, pp. 61-66.
43. Chen, Y., Miao, H., Lin, M., Fan, G., Hong, Z., Wu, H. and Wu, Y. (2006) Development and validation of a selective and robust LC-MS/MS method for high-througput quantifying rizatriptan in small plasma samples: Application to a clinical pharmacokinetic study. Journal of Chromatography B, 844, pp. 268-277.
44. Barrish, A., Olah, T. V., Gatto, G. J., Michel, K. B., Dobrinska, M. R. and Gilbert, J. D. (1996) The use of stable isotope labeling and liquid chromatography/tandem mass spectrometry techniques to study the pharmacokinetics and bioavailability of the antimigraine drug, MK-0462 (rizatriptan) in dogs. Rapid Communications in Mass Spectrometry, 10, pp. 1033-1037.
45. Antonucci, V., Wright, L. and Toma, P. (1998) The reversed-phase liquid chromatographic behaviour of the new 5-HT1D receptor agonist rizatriptan benzoate and its potential process impurities. The Journal of Liquid Chromatography & Related Technologies, 21, pp. 1649-1670.
46. Chen, J., Jiang, W., Ni, M., Gao, X.-L. and Zhang, Q.-Z. (2004) Liquid chromatographic method for the determination of rizatriptan in human plasma. Journal of Chromatography B, 805, pp. 169-173.
47. Mallikarjuna Rao, B., Sangaraju, S., Srinivasu, M. K., Madhavan, P., Lalitha, D. M., Kumar, P. R., Chandrasekhar, K. B., Arpitha, C. and Satya, B. T. (2006) Development and validation of a specific stability indicating high performance liquid chromatographic method for rizatriptan benzoate. Journal of Pharmaceutical and Biomedical Analysis, 41, pp. 1146-1151.
48. Cooper, J. D. H., Muirhead, J. E. and Taylor, J. E. (1999) Determination of eletriptan in plasma and saliva using automated sequential trace enrichment of dialysate and high performance liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis, 21, pp. 787-796.
49. Sagirli, O., Önal, A. and Sensoy, D. (2008) LC Assay of eletriptan in tablets and in vitro dissolution studies. Chromatographia, 68, pp. 269-273.
50. Zecevic, M., Jocic, B., Agatonovic-Kustrin, S. and Zivanovic, L. (2006) Validation of an HPLC method for the simultaneous determination of eletriptan and UK 120.413. Journal of the Serbian Chemical Society, 71, pp. 1195-1205.
51. Laugher, L., Briggs, R., Doughty, J. and Noctor, T. A. G. (2000) Development of an analytical methodology from toxicokinetic to clinical studies for the anti-migraine drug frovatriptan. Chromatographia, 52, pp. 113-119.
52. Khan, M., Viswanathan, B., Rao, D. S. and Reddy, R. (2007) Chiral separation of Frovatriptan isomers by HPLC using amylose based chiral stationary phase. Journal of Chromatography B, 846, pp. 119-123.
53. Phani, K. A., Ganesh, V. R. L., Subba, R. D. V., Anil, C., Venugopala, R. B., Hariharakrishnan, V. S., Suneetha, A. and Syama, S. B. (2008) A validated reversed phase HPLC method for the determination of process-related impurities in almotriptan malate API. Journal of Pharmaceutical and Biomedical Analysis, 46, pp. 792-798.
54. Dulery, B. D., Petty, M. A., Schoun, J., David, M. and Huebert, N. D. (1997) A method using a liquid chromatographic mass spectrometric assay for the determination of antimigraine compounds: Preliminary pharmacokinetics of MDL 74721, sumatriptan and naratriptan in rabbit. Journal of Pharmaceutical and Biomedical Analysis, 15, pp. 1009-1020.
55. Altria, K. D. and McLean, R. (1998) Development and optimization of generic micellar capillary chromatography method to support analysis of a wide range of pharmaceuticals and excipients. Journal of Pharmaceutical and Biomedical Analysis, 18, pp. 807-813.
56. Kauffmann, J. M. and Vire, J. C. (1993) Pharmaceutical and biomedical applications of electroanalysis. Analytica Chimica Acta, 273, p. 32.
57. Wang, J. (1988) Electroanalytical Techniques in Clinical Chemistry and Laboratory Medicine, Wiley, New York
58. Tanase, I. G. H. (2000) Tehnici şi Metode Electrometrice de Analizǎ, Ars Docendi Press, Bucureşti
59. Saka, C. and Sentürk, Z. (2008) Investigation of Redox Properties of Naratriptan, An Indole Derivative Compound Used in Migraine Treatment, and Its Voltammetric Analysis Doctoral Thesis, Yuzuncu Yil University Institute of Science, Van
60. Sagar, K., Alvarez, Z. M. F., Hua, C., Smyth, R. M. and Munden, R. (1992) Differential pulse voltammetric determination of sumatriptan succinate (1:1) in a tablet dosage form. Journal of Pharmaceutical and Biomedical Analysis, 2, pp. 17-21.
61. Aydoǧmu, Z. and Inanli, I. (2007) Extractive spectrophotometric methods for the determination of zolmitriptan in tablets. Journal of AOAC International, 90, pp. 1237-1241.
62. Altinöz, S., Uçar, G. and Yildiz, E. (2002) Determination of rizatriptan in its tablet dosage forms by UV spectrophotometric and spectrofluorimetric methods. Analytical Letters, 35, pp. 2471-2485.
63. Avadhanulu, A. B., Srinivas, J. S. and Anjaeyulu, Y. (1996) Reverse phase HPLC and colorimetric determintion of sumatriptan succinate in its drug form. Indian Drugs, 33, pp. 334-337.
64. Bebawy, L. I., Moustafa, A. A. and Abo-Talib, N. F. (2003) Stability-indicating methods for the determination of sumatriptan succinate. Journal of Pharmaceutical and Biomedical Analysis, 32, pp. 1123-1133.
65. Rochholz, G., Ahrens, B., König, F., Schütz, H. W., Schütz, H. and Seno, H. (1995) Screening and identification of sumatriptan and its main metabolite by means of thin-layer chromatography, ultraviolet spectroscopy and gas chromatography/mass spectrometry. Arzneimittelforschung, 45, pp. 941-946.
66. Altria, K. D., Chen, A. B. and Clohs, L. (2001) Capillary electrophoresis as a routine analytical tool in pharmaceutical analysis. LC-GC North America, 19, pp. 972-985.
67. Morzunova, T. G. (2006) Capillary electrophoresis in pharmaceutical analysis. Pharmaceutical Chemistry Journal, 40, pp. 158-170.
68. Khan, M., Viswanathan, B., Rao, D. S. and Reddy, G. S. (2006) A validated chiral CE method for Frovatriptan using cyclodextrin as chiral selector. Journal of Pharmaceutical and Biomedical Analysis, 41, pp. 1447-1452.
69. Altria, K. D. and Filbey, S. D. (1993) Quantitative analysis of sumatriptan by capillary electrophoresis. Journal of Liquid Chromatography, 16, pp. 2281-2292.
70. Wu, C.-Y., Di, B., Yao, X.-M., Yang, J. and Liu, W.-Y. (2006) Enantiomeric separation of zolmitriptan by CE with a sulfated β-cyclodextrin chiral selector. Chinese Pharmaceutical Journal University, 37, pp. 137-141.